TITLE

LIVER IRON GRADE IN DECOMPENSATED ALCOHOLIC LIVER DISEASE: PROGNOSTIC SIGNIFICANCE AND RELATION TO HFE GENOTYPE

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA88
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Moderate liver iron accumulation is common in alcoholic liver disease (ALD). Its causation is poorly understood but it has been associated with a poor outlook. 0, 1, 2, 3, and 4 iron was found in 41, 20, 12, 5, and 0 of the 78 patients respectively. Iron was seen in hepatocytes in 34 patients, biliary cells in 5, and Kupffer cells only in 2. In decompensated ALD, moderate liver iron accumulation common but is of limited clinical significance.
ACCESSION #
13219161

 

Related Articles

  • CASE FATALITY AND MORBIDITY IN PATIENTS WITH ALCOHOLIC LIVER DISEASE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA88 

    Alcoholic liver disease (ALD) is a heterogenous condition, in terms of its presentation, clinical course, and mortality. Available data on mortality at the national level show a rising trend in Great Britain in the face of a steady fall in many other European countries. A study was carried out...

  • comment. Greenslade, Lynda // Gastrointestinal Nursing;Jul/Aug2013, Vol. 11 Issue 6, p12 

    The author discusses the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report, which covers issues regarding patient care and in having recommendations for outcome improvement. The author cites how the said report challenges nurses in providing healthcare for...

  • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Harrison, S. A.; Oliver, D.; Arnold, H. L.; Gogia, S.; Neuschwander-Tetri, B. A. // Gut;Oct2008, Vol. 57 Issue 10, p1441 

    Background: Clinical predictors of advanced non-alcoholic liver disease (NAFLD) are needed to guide diagnostic evaluation and treatment. Methods: To better understand the demographics of NAFLD and risk factors for advanced disease, this study analysed 827 patients with NAFLD at two...

  • CLINICAL PROFILE OF CASES OF ALCOHOLIC LIVER DISEASE. Suthar, Hemang; Suthar, Kaushal; Mewada, Bhavna // International Journal of Medical Science & Public Health;2013, Vol. 2 Issue 2, p394 

    Background: Alcohol is most common substance abused. Alcoholic liver disease is a major health care problem in India. Alcohol consumption is directly associated with liver disease mortality and accounts for increased social and economic costs. Alcoholic liver disease may take the forms of acute...

  • Alcoholic Hepatitis . Helman, Richard A.; Temko, Michael H.; Nye, Sylvanus W.; Fallon, Harold J. // Annals of Internal Medicine;Mar71, Vol. 74 Issue 3, p311 

    Provides information on a number of patients with acute alcoholic hepatitis documented by liver biopsy during the healing phase. Effect of prednisolone therapy on the course and survival rate of patients with alcoholic hepatitis; Patient grouping for clinical severity of disease; Symptoms and...

  • Services for liver disease in the United Kingdom. Williams, Roger // BMJ: British Medical Journal (International Edition);10/15/2005, Vol. 331 Issue 7521, p858 

    Presents an editorial regarding services for liver disease in Great Britain. Increase of mortality from liver disease; List of liver diseases, including alcoholic liver disease, hepatitis C virus, primary hepatocellular cancer, cholangiocarcinoma, and steatohepatitis; Lack of surgeons with...

  • Liquid assets. Mayer, Chris; Houghton, Graham; Cowell, Roger; Scullion, Jane // Nursing Standard;11/16/2005, Vol. 20 Issue 10, p30 

    Presents letters to the editor regarding readers opinion on liver transplants to an alcoholic patients. "Most People Will Quit If the Alternative Is Death," comments on the negative scenario poses by the message regarding alcoholism; "Patients Must Show a Clear Commitments," focuses on the...

  • Glucocorticoids plus N-Acetylcysteine in Alcoholic Hepatitis.  // New England Journal of Medicine;2/2/2012, Vol. 366 Issue 5, p476 

    The article presents a study on whether combination therapy with glucocorticoids plus N-acetylcysteine would improve the survival of alcoholic hepatitis patients. The researchers assigned 174 patients randomly to receive prednisolone and N-acetylcysteine or only prednisolone. They found that the...

  • Biochemical and Clinical Effects of Aspartame in Patients with Chronic, Stable Alcoholic Liver Disease. Hertelendy, Zsolt I.; Mendenhall, Charles L.; Rouster, Susan D.; Marshall, Laine; Weesner, Robert // American Journal of Gastroenterology;May1993, Vol. 88 Issue 5, p737 

    Aspartame is an artificial sweetener completely metabolized in the gut and absorbed as aspartate, phenylalanine, and methanol. Phenylalanine is thought to mediate or exacerbate hepatic encephalopathy, and an impaired liver may not be able to cope with the ammoniagenic properties of the amino...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics